Literature DB >> 9207812

Over-the-counter and alternative medicines in the treatment of chronic vaginal symptoms.

P Nyirjesy1, M V Weitz, M H Grody, B Lorber.   

Abstract

OBJECTIVE: To investigate the use of over-the-counter and alternative medicines in women with chronic vaginal symptoms.
METHODS: One hundred five patients, referred by their gynecologists for evaluation of chronic vaginal symptoms, were interviewed about their use of over-the-counter and alternative medicines during the preceding year, the amount of money spent on each, and whether or not their physicians had been informed of these treatments.
RESULTS: The mean age was 36 years, and one-half had finished college. The median symptom duration was 2 years. Seventy-seven (73.3%) patients had self-treated with over-the-counter medications such as miconazole (74% of over-the-counter users), clotrimazole (38.2%), or povidone-iodine (13.2%). The median expenditure for over-the-counter use was %0 (range $2-1000). Forty-four (41.9%) had used alternative medicines, most frequently acidophilus pills orally (50%) vaginally (11.4%), yogurt orally (20.5%) or vaginally (18.2%), vinegar douches (13.6%), and boric acid (13.6%). The median expenditure for alternative medicines was $35 (range $0-1200). Fewer physicians were aware of the use of alternative (70.5%) that of over-the-counter medicines (88.3%). Although most patients thought that vulvovaginal candidiasis was the cause of their symptoms, the most common diagnoses at initial presentation were candidiasis in 29 (27.6%), vulvar vestibulitis in 18 (17.1%), irritant dermatitis in 16 (15.2%), and bacterial vaginosis in 11 (10.5%). Women who actually had candidiasis were more likely to have used alternative medicines (odds ration 2.31, 95% confidence interval 1.00, 5.42) than other patients.
CONCLUSION: Women with chronic vaginal symptoms often use over-the-counter and alternative medicines that add to health care costs and are unlikely to be of benefit.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9207812     DOI: 10.1016/S0029-7844(97)00242-1

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  21 in total

1.  Vulvar Vestibulitis Syndrome: A Post-infectious Entity?

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-12       Impact factor: 3.725

2.  The development of evidence-based guidelines for over-the-counter treatment of vulvovaginal candidiasis.

Authors:  Christine M Bond; Margaret C Watson
Journal:  Pharm World Sci       Date:  2003-08

3.  Chronic vulvar irritation: could toilet paper be the culprit?

Authors:  Jo Ann Majerovich; Andrea Canty; Baukje Miedema
Journal:  Can Fam Physician       Date:  2010-04       Impact factor: 3.275

4.  Over-the-counter treatments and perineal hygiene in postmenopausal women.

Authors:  Elisabeth A Erekson; Deanna K Martin; E Christine Brousseau; Sallis O Yip; Terri R Fried
Journal:  Menopause       Date:  2014-03       Impact factor: 2.953

5.  Cromolyn cream for recalcitrant idiopathic vulvar vestibulitis: results of a placebo controlled study.

Authors:  P Nyirjesy; J D Sobel; M V Weitz; D J Leaman; M J Small; S P Gelone
Journal:  Sex Transm Infect       Date:  2001-02       Impact factor: 3.519

6.  Clotrimazole-cyclodextrin based approach for the management and treatment of Candidiasis - A formulation and chemistry-based evaluation.

Authors:  Noorullah Naqvi Mohammed; Pankaj Pandey; Nayaab S Khan; Khaled M Elokely; Haining Liu; Robert J Doerksen; Michael A Repka
Journal:  Pharm Dev Technol       Date:  2015-04-29       Impact factor: 3.133

7.  Her choice: dealing with lactobacilli, vaginitis, and antibiotics.

Authors:  Marie V Pirotta; Suzanne M Garland
Journal:  Curr Infect Dis Rep       Date:  2005-11       Impact factor: 3.725

8.  Effect of lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: a randomised controlled trial.

Authors:  Marie Pirotta; Jane Gunn; Patty Chondros; Sonia Grover; Paula O'Malley; Susan Hurley; Suzanne Garland
Journal:  BMJ       Date:  2004-08-27

9.  Formulation, Pharmacological Evaluation, and Efficacy Studies of Occidiofungin, a Novel Antifungal.

Authors:  Akshaya Ravichandran; Jerome Escano; Jung Hwa Lee; Matthew K Ross; Frank Austin; Ravi Orugunty; Shi-En Lu; Leif Smith
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

10.  Bacterial vaginosis during pregnancy. Should we screen for and treat it?

Authors:  Adrienne Einarson; Gideon Koren
Journal:  Can Fam Physician       Date:  2002-05       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.